Distinguishing features of Long COVID identified through immune profiling
By
Jon Klein,
Jamie Wood,
Jillian Jaycox,
Peiwen Lu,
Rahul M. Dhodapkar,
Jeffrey R. Gehlhausen,
Alexandra Tabachnikova,
Laura Tabacof,
Amyn A. Malik,
Kathy Kamath,
Kerrie Greene,
Valter Silva Monteiro,
Mario Pena-Hernandez,
Tianyang Mao,
Bornali Bhattacharjee,
Takehiro Takahashi,
Carolina Lucas,
Julio Silva,
Dayna Mccarthy,
Erica Breyman,
Jenna Tosto-Mancuso,
Yile Dai,
Emily Perotti,
Koray Akduman,
Tiffany Tzeng,
Lan Xu,
Inci Yildirim,
Harlan M. Krumholz,
John Shon,
Ruslan Medzhitov,
Saad B. Omer,
David van Dijk,
Aaron M. Ring,
David Putrino,
Akiko Iwasaki
Posted 10 Aug 2022
medRxiv DOI: 10.1101/2022.08.09.22278592
SARS-CoV-2 infection can result in the development of a constellation of persistent sequelae following acute disease called post-acute sequelae of COVID-19 (PASC) or Long COVID. Individuals diagnosed with Long COVID frequently report unremitting fatigue, post-exertional malaise, and a variety of cognitive and autonomic dysfunctions; however, the basic biological mechanisms responsible for these debilitating symptoms are unclear. Here, 215 individuals were included in an exploratory, cross-sectional study to perform multi-dimensional immune phenotyping in conjunction with machine learning methods to identify key immunological features distinguishing Long COVID. Marked differences were noted in specific circulating myeloid and lymphocyte populations relative to matched control groups, as well as evidence of elevated humoral responses directed against SARS-CoV-2 among participants with Long COVID. Further, unexpected increases were observed in antibody responses directed against non-SARS-CoV-2 viral pathogens, particularly Epstein-Barr virus. Analysis of circulating immune mediators and various hormones also revealed pronounced differences, with levels of cortisol being uniformly lower among participants with Long COVID relative to matched control groups. Integration of immune phenotyping data into unbiased machine learning models identified significant distinguishing features critical in accurate classification of Long COVID, with decreased levels of cortisol being the most significant individual predictor. These findings will help guide additional studies into the pathobiology of Long COVID and may aid in the future development of objective biomarkers for Long COVID.
Download data
- Downloaded 31,261 times
- Download rankings, all-time:
- Site-wide: 344
- In infectious diseases: 135
- Year to date:
- Site-wide: 63
- Since beginning of last month:
- Site-wide: 32
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!